Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs
- 31 December 2009
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 14 (23-24), 1089-1097
- https://doi.org/10.1016/j.drudis.2009.09.003
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- DNA Mismatch Binding and Antiproliferative Activity of Rhodium MetalloinsertorsJournal of the American Chemical Society, 2009
- Catalytic organometallic anticancer complexesProceedings of the National Academy of Sciences of the United States of America, 2008
- Metal and Ligand Control of Sulfenate Reactivity: Arene Ruthenium Thiolato‐Mono‐S‐OxidesAngewandte Chemie, 2008
- Inhibition of cathepsin B by Au(I) complexes: a kinetic and computational studyJBIC Journal of Biological Inorganic Chemistry, 2008
- A potent cytotoxic photoactivated platinum complexProceedings of the National Academy of Sciences of the United States of America, 2007
- Gold(III)-Dithiocarbamato Complexes Induce Cancer Cell Death Triggered by Thioredoxin Redox System Inhibition and Activation of ERK PathwayCell Chemical Biology, 2007
- Insertion of a Bulky Rhodium Complex into a DNA Cytosine−Cytosine Mismatch: An NMR Solution StudyJournal of the American Chemical Society, 2007
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- Soluble Single-Walled Carbon Nanotubes as Longboat Delivery Systems for Platinum(IV) Anticancer Drug DesignJournal of the American Chemical Society, 2007
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005